RU2719480C2 - Способ получения производного диазабициклооктана и его промежуточного соединения - Google Patents

Способ получения производного диазабициклооктана и его промежуточного соединения Download PDF

Info

Publication number
RU2719480C2
RU2719480C2 RU2016115767A RU2016115767A RU2719480C2 RU 2719480 C2 RU2719480 C2 RU 2719480C2 RU 2016115767 A RU2016115767 A RU 2016115767A RU 2016115767 A RU2016115767 A RU 2016115767A RU 2719480 C2 RU2719480 C2 RU 2719480C2
Authority
RU
Russia
Prior art keywords
benzyloxy
tert
amino
compound represented
formula
Prior art date
Application number
RU2016115767A
Other languages
English (en)
Russian (ru)
Other versions
RU2016115767A (ru
RU2016115767A3 (enExample
Inventor
Такао АБЕ
Такеси ФУРУУТИ
Йосиаки САКАМАКИ
Накако МИЦУХАСИ
Original Assignee
Мейдзи Сейка Фарма Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мейдзи Сейка Фарма Ко., Лтд. filed Critical Мейдзи Сейка Фарма Ко., Лтд.
Publication of RU2016115767A publication Critical patent/RU2016115767A/ru
Publication of RU2016115767A3 publication Critical patent/RU2016115767A3/ru
Application granted granted Critical
Publication of RU2719480C2 publication Critical patent/RU2719480C2/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Hydrogenated Pyridines (AREA)
RU2016115767A 2013-09-24 2014-09-24 Способ получения производного диазабициклооктана и его промежуточного соединения RU2719480C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013197110 2013-09-24
JP2013-197110 2013-09-24
PCT/JP2014/075203 WO2015046207A1 (ja) 2013-09-24 2014-09-24 ジアザビシクロオクタン誘導体の製造法とその中間体

Publications (3)

Publication Number Publication Date
RU2016115767A RU2016115767A (ru) 2017-10-26
RU2016115767A3 RU2016115767A3 (enExample) 2018-06-29
RU2719480C2 true RU2719480C2 (ru) 2020-04-17

Family

ID=52743343

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2016115767A RU2719480C2 (ru) 2013-09-24 2014-09-24 Способ получения производного диазабициклооктана и его промежуточного соединения

Country Status (22)

Country Link
US (2) US10000491B2 (enExample)
EP (1) EP3050883B1 (enExample)
JP (1) JP6453222B2 (enExample)
KR (1) KR102239725B1 (enExample)
CN (2) CN105555787B (enExample)
AR (5) AR097744A1 (enExample)
AU (1) AU2014324302B2 (enExample)
BR (1) BR112016006246B8 (enExample)
CA (1) CA2924953C (enExample)
DK (1) DK3050883T3 (enExample)
ES (1) ES2793201T3 (enExample)
HK (1) HK1244487A1 (enExample)
HU (1) HUE049027T2 (enExample)
IL (1) IL244740B (enExample)
MX (2) MX367578B (enExample)
MY (2) MY176278A (enExample)
NZ (1) NZ718009A (enExample)
RU (1) RU2719480C2 (enExample)
SG (1) SG11201602256UA (enExample)
TW (1) TWI644908B (enExample)
WO (1) WO2015046207A1 (enExample)
ZA (1) ZA201602053B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA117734C2 (uk) 2012-05-30 2018-09-25 Мейдзі Сейка Фарма Ко., Лтд. НОВИЙ ІНГІБІТОР β-ЛАКТАМАЗИ І СПОСІБ ЙОГО ОДЕРЖАННЯ
MY176278A (en) 2013-09-24 2020-07-27 Meiji Seika Pharma Co Ltd Process for producing diazabicyclooctane derivative and intermediate thereof
NZ757221A (en) * 2013-10-08 2021-12-24 Meiji Seika Pharma Co Ltd Crystalline forms of diazabicyclooctane derivative and production process thereof
BR112017010445B8 (pt) * 2014-12-05 2024-02-27 Meiji Seika Pharma Co Ltd Processo de produção de cristais de derivado de diazabiciclo-octano e preparação liofilizada estável
CA2944306C (en) 2015-10-30 2023-11-14 The Toronto-Dominion Bank Validating encrypted data from a multi-layer token
US11216808B2 (en) 2015-11-04 2022-01-04 The Toronto-Dominion Bank Token-based system for excising data from databases
JP2020011901A (ja) * 2016-10-20 2020-01-23 協和キリン株式会社 ピロリジン化合物の製造方法
CN106699756B (zh) * 2016-12-30 2019-10-29 淄博鑫泉医药技术服务有限公司 β内酰胺酶抑制剂阿维巴坦的合成方法
CA3076959C (en) 2017-09-27 2025-02-11 Meiji Seika Pharma Co., Ltd. CRYSTALLINE FORMS OF DIAZABICYCLOOCTANE DERIVATIVES AND THEIR PRODUCTION PROCESS
TW201920174A (zh) 2017-09-27 2019-06-01 瑞士商羅氏大藥廠股份有限公司 二氮雜雙環辛烷衍生物之醫藥形式及其製法
KR20200091396A (ko) 2017-09-27 2020-07-30 페도라 파마슈티칼스 인코포레이티드 디아자비시클로옥탄 유도체의 약제학적 형태 및 그의 제조 방법
CN109678856B (zh) * 2017-10-18 2020-09-25 新发药业有限公司 一种阿维巴坦中间体的制备方法
WO2019101722A1 (en) 2017-11-23 2019-05-31 F. Hoffmann-La Roche Ag Proline hydroxylases as well as uses, methods and products involving the same
US11957690B2 (en) 2018-07-16 2024-04-16 Brown University Chromogenic beta-lactamase substrate
US11897844B2 (en) * 2018-09-21 2024-02-13 Api Corporation Method for producing amino acid derivatives
US12195755B2 (en) 2019-05-20 2025-01-14 Brown University Placental lipid bilayer for cell-free molecular interaction studies
WO2021038403A1 (en) 2019-08-30 2021-03-04 DePuy Synthes Products, Inc. Electrical device for monitoring, prevention, and treatment of implant infections
CN121021508A (zh) * 2025-10-29 2025-11-28 北京耀诚惠仁科技有限公司 β-内酰胺酶抑制剂中间体共晶或盐及其制备方法和应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2124014C1 (ru) * 1993-12-29 1998-12-27 Пфайзер Инк. Диазабициклические соединения и содержащая их фармацевтическая композиция
CA2822758A1 (en) * 2010-12-22 2012-06-28 Meiji Seika Pharma Co., Ltd. Optically active diazabicyclooctane derivative and process for preparing the same
WO2012172368A1 (en) * 2011-06-17 2012-12-20 Astrazeneca Ab Process for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5038509B1 (enExample) 1970-10-21 1975-12-10
JPS538509A (en) 1976-07-13 1978-01-26 Toshiba Corp Impedance matching system for data transmission circuit
JPS6019759B2 (ja) 1977-11-24 1985-05-17 イ−ライ・リリ−・アンド・カンパニ− 非経口投予用11115152139199東京都中央区京橋2丁目3番13号
GB1589317A (en) 1977-11-24 1981-05-13 Lilly Co Eli Freeze drying cephalothin sodium
JPS60255723A (ja) 1984-05-31 1985-12-17 Ono Pharmaceut Co Ltd メシル酸ガベキサートの結晶性凍結乾燥製剤及びその製造方法
JPH07117533B2 (ja) 1985-08-28 1995-12-18 株式会社生体科学研究所 トランスフエリンおよびその用途
US20030220521A1 (en) 1989-07-27 2003-11-27 G.D. Searle & Co. Renal-selective prodrugs for control of renal sympathetic nerve activity in the treatment of hypertension
TW264475B (enExample) 1991-09-20 1995-12-01 Takeda Pharm Industry Co Ltd
JP2843444B2 (ja) 1994-05-02 1999-01-06 塩野義製薬株式会社 ピロリジルチオカルバペネム誘導体の結晶,該結晶を含む凍結乾燥製剤,およびその製造方法
CN1048248C (zh) 1994-05-02 2000-01-12 盐野义制药株式会社 吡咯烷基硫基碳代青霉烯衍生物的结晶、含该结晶的冷冻干燥制剂及其制造方法
FR2812635B1 (fr) 2000-08-01 2002-10-11 Aventis Pharma Sa Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens
FR2815420B1 (fr) 2000-10-16 2003-05-16 Cit Alcatel Compensation de la dispersion chromatique dans un systeme de transmission a fibre optique, et fibre de compensation
FR2825705B1 (fr) 2001-06-08 2005-05-20 Aventis Pharma Sa Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens
FR2835186B1 (fr) 2002-01-28 2006-10-20 Aventis Pharma Sa Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases
FR2921060B1 (fr) 2007-09-14 2012-06-15 Novexel Nouveau procede de preparation d'une piperidine disubsituee et nouveaux intermediaires
SI2231667T1 (sl) 2008-01-18 2013-12-31 Merck Sharp & Dohme Corp. Beta laktamazni inhibitorji
FR2930553B1 (fr) 2008-04-29 2010-05-21 Novexel Composes azabicycliques, leur preparation et leur utilisation comme medicaments, notamment inhibiteurs de beta-lactamases
FR2936798B1 (fr) 2008-10-03 2012-09-28 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens.
WO2010126820A2 (en) 2009-04-30 2010-11-04 Merck Sharp & Dohme Corp. Preparation of alkyl esters of n-protected oxo-azacycloalkylcarboxylic acids
FR2951171A1 (fr) 2009-10-09 2011-04-15 Novexel Nouveau sel de sodium d'un compose azabicyclique sous forme enantiomere cristallisee et nouvelles formes polymorphes et pseudopolymorphes ainsi que leur preparation
JP2012122603A (ja) 2010-11-15 2012-06-28 Nifco Inc コネクタ装置
US8772490B2 (en) 2010-12-22 2014-07-08 Meiji Seika Pharma Co., Ltd. Optically active diazabicyclooctane derivatives and process for preparing the same
KR101512738B1 (ko) 2011-08-27 2015-04-17 욱크하르트 리미티드 1,6-디아자-비시클로[3,2,1]옥탄-7-온 유도체 및 세균 감염 치료에서의 그 유도체의 용도
JP5677634B2 (ja) 2011-08-30 2015-02-25 ウォックハート リミテッド 1,6−ジアザビシクロ[3,2,1]オクタン−7−オン誘導体および細菌感染の処置におけるそれらの使用
EP3052497B1 (en) 2011-09-13 2017-06-28 Wockhardt Limited Nitrogen containing compounds and their use
US8796257B2 (en) 2011-12-02 2014-08-05 Naeja Pharmaceutical Inc. Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
US9505761B2 (en) 2011-12-02 2016-11-29 Fedora Pharmaceuticals Inc. Bicyclic compounds and their use as antibacterial agents and beta-lactamase inhibitors
UA117734C2 (uk) 2012-05-30 2018-09-25 Мейдзі Сейка Фарма Ко., Лтд. НОВИЙ ІНГІБІТОР β-ЛАКТАМАЗИ І СПОСІБ ЙОГО ОДЕРЖАННЯ
MY176278A (en) 2013-09-24 2020-07-27 Meiji Seika Pharma Co Ltd Process for producing diazabicyclooctane derivative and intermediate thereof
NZ757221A (en) * 2013-10-08 2021-12-24 Meiji Seika Pharma Co Ltd Crystalline forms of diazabicyclooctane derivative and production process thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2124014C1 (ru) * 1993-12-29 1998-12-27 Пфайзер Инк. Диазабициклические соединения и содержащая их фармацевтическая композиция
CA2822758A1 (en) * 2010-12-22 2012-06-28 Meiji Seika Pharma Co., Ltd. Optically active diazabicyclooctane derivative and process for preparing the same
WO2012172368A1 (en) * 2011-06-17 2012-12-20 Astrazeneca Ab Process for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof

Also Published As

Publication number Publication date
CA2924953C (en) 2021-12-07
US20170283415A1 (en) 2017-10-05
MX2016003867A (es) 2016-08-04
US20160264573A1 (en) 2016-09-15
BR112016006246A2 (enExample) 2017-08-22
AR097744A1 (es) 2016-04-13
TWI644908B (zh) 2018-12-21
ES2793201T3 (es) 2020-11-13
MY176278A (en) 2020-07-27
EP3050883B1 (en) 2020-04-22
RU2016115767A (ru) 2017-10-26
IL244740B (en) 2018-11-29
US10000491B2 (en) 2018-06-19
HUE049027T2 (hu) 2020-08-28
CN105555787B (zh) 2017-08-08
AR131189A2 (es) 2025-02-26
ZA201602053B (en) 2019-06-26
JPWO2015046207A1 (ja) 2017-03-09
MY193210A (en) 2022-09-26
EP3050883A1 (en) 2016-08-03
BR112016006246B1 (pt) 2021-09-08
MX372585B (es) 2020-04-17
AU2014324302A1 (en) 2016-05-12
SG11201602256UA (en) 2016-04-28
IL244740A0 (en) 2016-04-21
DK3050883T3 (da) 2020-05-25
BR112016006246B8 (pt) 2021-10-05
WO2015046207A1 (ja) 2015-04-02
CN107501264A (zh) 2017-12-22
AU2014324302B2 (en) 2018-02-15
AR131190A2 (es) 2025-02-26
RU2016115767A3 (enExample) 2018-06-29
JP6453222B2 (ja) 2019-01-16
KR20160058851A (ko) 2016-05-25
NZ718009A (en) 2018-03-23
TW201546059A (zh) 2015-12-16
AR131188A2 (es) 2025-02-26
KR102239725B1 (ko) 2021-04-12
US10000492B2 (en) 2018-06-19
CA2924953A1 (en) 2015-04-02
CN105555787A (zh) 2016-05-04
AR131186A2 (es) 2025-02-26
HK1244487A1 (zh) 2018-08-10
HK1219473A1 (zh) 2017-04-07
EP3050883A4 (en) 2017-05-10
MX367578B (es) 2019-08-27

Similar Documents

Publication Publication Date Title
RU2719480C2 (ru) Способ получения производного диазабициклооктана и его промежуточного соединения
US12103928B2 (en) Processes for preparing a diazabicyclooctane compound
JP7182677B2 (ja) ジアザビシクロオクタン誘導体の結晶とその製造法
RU2838718C2 (ru) Кристаллические формы производного диазабициклооктана и способ их получения
RU2840014C2 (ru) Кристаллические формы производного диазабициклооктана и способ их получения
HK1226406A1 (en) Production method for diazabicyclooctane derivatives and intermediates
RU2847390C2 (ru) Кристаллические формы производного диазабициклооктана и способ их получения
RU2800050C2 (ru) НОВЫЙ ИНГИБИТОР β-ЛАКТАМАЗЫ И СПОСОБ ЕГО ПОЛУЧЕНИЯ
HK1219473B (en) Production method for diazabicyclooctane derivative and intermediary body thereof
HK1226406B (en) Production method for diazabicyclooctane derivatives and intermediates
RU2801220C2 (ru) Кристаллические формы производного диазабициклооктана и способ их получения